Painkiller trial raises questions for FDA, Pfizer

By Shannon Brownlee and Jeanne Lenzer

In February 2005, the U.S. Food and Drug Administration (FDA) called a three-day hearing to review the risks of three painkillers known as C

Related to this story

Heart testing bill signed by Perry required unnecessary tests, critics charge

By Rochelle Sharpe

Drug makers' dime funds Congressional travel

By Robert Brodsky

More big money from pharmaceutical lobby in 2008

By Mary Beth Lombardo

Checkbook politics

By Victoria Kreha

Excerpts from this story referencing "Celecoxib":

"… on the study known as PRECISION (the Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen). PRECISION is a $100 milli …"